Cargando…
High‐grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer
In the era of personalized medicine, where transition from organ‐based to individualized genetic diagnosis takes place, the tailoring of treatment in cancer becomes increasingly important. This is particularly true for high‐grade, advanced FIGO stage serous adenocarcinomas of the ovary (OC), fallopi...
Autores principales: | Jacob, Francis, Marchetti, Rosa Lina, Kind, André B., Russell, Kenneth, Schoetzau, Andreas, Heinzelmann‐Schwarz, Viola A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782088/ https://www.ncbi.nlm.nih.gov/pubmed/33016563 http://dx.doi.org/10.1002/1878-0261.12811 |
Ejemplares similares
-
Outcome in serous ovarian cancer is not associated with LATS expression
por: Montavon, Céline, et al.
Publicado: (2019) -
Diaphragmatic smears are not of additional benefit in the detection of peritoneal spread in gynecological cancers
por: Montavon, Celine, et al.
Publicado: (2018) -
The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012) -
Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment
por: Vetter, Marcus, et al.
Publicado: (2022) -
Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)